Copyright Reports & Markets. All rights reserved.

Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Research Report 2021

Request for Sample of this report
Buy now

1 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Overview

  • 1.1 Product Overview and Scope of COVID-19 IgM/IgG Antibody Rapid Test Kits
  • 1.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Segment by Type
    • 1.2.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 RDT(Rapid Diagnostic Test)
    • 1.2.3 ELISA(Enzyme-linked Immunosorbent Aassay)
    • 1.2.4 Neutralization Assay
  • 1.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Segment by Application
    • 1.3.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Special Clinic
    • 1.3.4 Research Institutions
  • 1.4 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Estimates and Forecasts
    • 1.4.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue 2016-2027
    • 1.4.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Sales 2016-2027
    • 1.4.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size by Region: 2016 Versus 2021 Versus 2027

2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Competition by Manufacturers

  • 2.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers COVID-19 IgM/IgG Antibody Rapid Test Kits Manufacturing Sites, Area Served, Product Type
  • 2.5 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Competitive Situation and Trends
    • 2.5.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest COVID-19 IgM/IgG Antibody Rapid Test Kits Players Market Share by Revenue
    • 2.5.3 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 COVID-19 IgM/IgG Antibody Rapid Test Kits Retrospective Market Scenario by Region

  • 3.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Facts & Figures by Country
    • 3.3.1 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Sales by Country
    • 3.3.2 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Market Facts & Figures by Country
    • 3.4.1 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Sales by Country
    • 3.4.2 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Market Facts & Figures by Region
    • 3.5.1 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Sales by Region
    • 3.5.2 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Facts & Figures by Country
    • 3.6.1 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Sales by Country
    • 3.6.2 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa COVID-19 IgM/IgG Antibody Rapid Test Kits Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa COVID-19 IgM/IgG Antibody Rapid Test Kits Sales by Country
    • 3.7.2 Middle East and Africa COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Historic Market Analysis by Type

  • 4.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Sales Market Share by Type (2016-2021)
  • 4.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue Market Share by Type (2016-2021)
  • 4.3 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Price by Type (2016-2021)

5 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Historic Market Analysis by Application

  • 5.1 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Sales Market Share by Application (2016-2021)
  • 5.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Revenue Market Share by Application (2016-2021)
  • 5.3 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Cellex
    • 6.1.1 Cellex Corporation Information
    • 6.1.2 Cellex Description and Business Overview
    • 6.1.3 Cellex COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Cellex Product Portfolio
    • 6.1.5 Cellex Recent Developments/Updates
  • 6.2 RayBiotech
    • 6.2.1 RayBiotech Corporation Information
    • 6.2.2 RayBiotech Description and Business Overview
    • 6.2.3 RayBiotech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 RayBiotech Product Portfolio
    • 6.2.5 RayBiotech Recent Developments/Updates
  • 6.3 Biopanda
    • 6.3.1 Biopanda Corporation Information
    • 6.3.2 Biopanda Description and Business Overview
    • 6.3.3 Biopanda COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Biopanda Product Portfolio
    • 6.3.5 Biopanda Recent Developments/Updates
  • 6.4 BioMedomics
    • 6.4.1 BioMedomics Corporation Information
    • 6.4.2 BioMedomics Description and Business Overview
    • 6.4.3 BioMedomics COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BioMedomics Product Portfolio
    • 6.4.5 BioMedomics Recent Developments/Updates
  • 6.5 GenBody
    • 6.5.1 GenBody Corporation Information
    • 6.5.2 GenBody Description and Business Overview
    • 6.5.3 GenBody COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GenBody Product Portfolio
    • 6.5.5 GenBody Recent Developments/Updates
  • 6.6 SD Biosensor
    • 6.6.1 SD Biosensor Corporation Information
    • 6.6.2 SD Biosensor Description and Business Overview
    • 6.6.3 SD Biosensor COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 SD Biosensor Product Portfolio
    • 6.6.5 SD Biosensor Recent Developments/Updates
  • 6.7 Advaite
    • 6.6.1 Advaite Corporation Information
    • 6.6.2 Advaite Description and Business Overview
    • 6.6.3 Advaite COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Advaite Product Portfolio
    • 6.7.5 Advaite Recent Developments/Updates
  • 6.8 Premier Biotech
    • 6.8.1 Premier Biotech Corporation Information
    • 6.8.2 Premier Biotech Description and Business Overview
    • 6.8.3 Premier Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Premier Biotech Product Portfolio
    • 6.8.5 Premier Biotech Recent Developments/Updates
  • 6.9 Epitope Diagnostics
    • 6.9.1 Epitope Diagnostics Corporation Information
    • 6.9.2 Epitope Diagnostics Description and Business Overview
    • 6.9.3 Epitope Diagnostics COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Epitope Diagnostics Product Portfolio
    • 6.9.5 Epitope Diagnostics Recent Developments/Updates
  • 6.10 CTK Biotech
    • 6.10.1 CTK Biotech Corporation Information
    • 6.10.2 CTK Biotech Description and Business Overview
    • 6.10.3 CTK Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 CTK Biotech Product Portfolio
    • 6.10.5 CTK Biotech Recent Developments/Updates
  • 6.11 Creative Diagnostics
    • 6.11.1 Creative Diagnostics Corporation Information
    • 6.11.2 Creative Diagnostics COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.11.3 Creative Diagnostics COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Creative Diagnostics Product Portfolio
    • 6.11.5 Creative Diagnostics Recent Developments/Updates
  • 6.12 Eagle Biosciences
    • 6.12.1 Eagle Biosciences Corporation Information
    • 6.12.2 Eagle Biosciences COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.12.3 Eagle Biosciences COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Eagle Biosciences Product Portfolio
    • 6.12.5 Eagle Biosciences Recent Developments/Updates
  • 6.13 Sure Biotech
    • 6.13.1 Sure Biotech Corporation Information
    • 6.13.2 Sure Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.13.3 Sure Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Sure Biotech Product Portfolio
    • 6.13.5 Sure Biotech Recent Developments/Updates
  • 6.14 Sugentech
    • 6.14.1 Sugentech Corporation Information
    • 6.14.2 Sugentech COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.14.3 Sugentech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Sugentech Product Portfolio
    • 6.14.5 Sugentech Recent Developments/Updates
  • 6.15 Sensing self
    • 6.15.1 Sensing self Corporation Information
    • 6.15.2 Sensing self COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.15.3 Sensing self COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Sensing self Product Portfolio
    • 6.15.5 Sensing self Recent Developments/Updates
  • 6.16 Euroimmun AG
    • 6.16.1 Euroimmun AG Corporation Information
    • 6.16.2 Euroimmun AG COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.16.3 Euroimmun AG COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Euroimmun AG Product Portfolio
    • 6.16.5 Euroimmun AG Recent Developments/Updates
  • 6.17 PharmACT
    • 6.17.1 PharmACT Corporation Information
    • 6.17.2 PharmACT COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.17.3 PharmACT COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 PharmACT Product Portfolio
    • 6.17.5 PharmACT Recent Developments/Updates
  • 6.18 Liming Bio
    • 6.18.1 Liming Bio Corporation Information
    • 6.18.2 Liming Bio COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.18.3 Liming Bio COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Liming Bio Product Portfolio
    • 6.18.5 Liming Bio Recent Developments/Updates
  • 6.19 Beijing Wantai
    • 6.19.1 Beijing Wantai Corporation Information
    • 6.19.2 Beijing Wantai COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.19.3 Beijing Wantai COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Beijing Wantai Product Portfolio
    • 6.19.5 Beijing Wantai Recent Developments/Updates
  • 6.20 Livzon Diagnostics
    • 6.20.1 Livzon Diagnostics Corporation Information
    • 6.20.2 Livzon Diagnostics COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.20.3 Livzon Diagnostics COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Livzon Diagnostics Product Portfolio
    • 6.20.5 Livzon Diagnostics Recent Developments/Updates
  • 6.21 Shenzhen BioEasy Biotechnology
    • 6.21.1 Shenzhen BioEasy Biotechnology Corporation Information
    • 6.21.2 Shenzhen BioEasy Biotechnology COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.21.3 Shenzhen BioEasy Biotechnology COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Shenzhen BioEasy Biotechnology Product Portfolio
    • 6.21.5 Shenzhen BioEasy Biotechnology Recent Developments/Updates
  • 6.22 Orient Gene Biotech
    • 6.22.1 Orient Gene Biotech Corporation Information
    • 6.22.2 Orient Gene Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.22.3 Orient Gene Biotech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Orient Gene Biotech Product Portfolio
    • 6.22.5 Orient Gene Biotech Recent Developments/Updates
  • 6.23 INNOVITA
    • 6.23.1 INNOVITA Corporation Information
    • 6.23.2 INNOVITA COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.23.3 INNOVITA COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 INNOVITA Product Portfolio
    • 6.23.5 INNOVITA Recent Developments/Updates
  • 6.24 Dynamiker
    • 6.24.1 Dynamiker Corporation Information
    • 6.24.2 Dynamiker COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.24.3 Dynamiker COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Dynamiker Product Portfolio
    • 6.24.5 Dynamiker Recent Developments/Updates
  • 6.25 Guangzhou Wonfo Bio-Tech
    • 6.25.1 Guangzhou Wonfo Bio-Tech Corporation Information
    • 6.25.2 Guangzhou Wonfo Bio-Tech COVID-19 IgM/IgG Antibody Rapid Test Kits Description and Business Overview
    • 6.25.3 Guangzhou Wonfo Bio-Tech COVID-19 IgM/IgG Antibody Rapid Test Kits Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 Guangzhou Wonfo Bio-Tech Product Portfolio
    • 6.25.5 Guangzhou Wonfo Bio-Tech Recent Developments/Updates

7 COVID-19 IgM/IgG Antibody Rapid Test Kits Manufacturing Cost Analysis

  • 7.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of COVID-19 IgM/IgG Antibody Rapid Test Kits
  • 7.4 COVID-19 IgM/IgG Antibody Rapid Test Kits Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Distributors List
  • 8.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Customers

9 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Dynamics

  • 9.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Industry Trends
  • 9.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Growth Drivers
  • 9.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Challenges
  • 9.4 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Restraints

10 Global Market Forecast

  • 10.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of COVID-19 IgM/IgG Antibody Rapid Test Kits by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of COVID-19 IgM/IgG Antibody Rapid Test Kits by Type (2022-2027)
  • 10.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of COVID-19 IgM/IgG Antibody Rapid Test Kits by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of COVID-19 IgM/IgG Antibody Rapid Test Kits by Application (2022-2027)
  • 10.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of COVID-19 IgM/IgG Antibody Rapid Test Kits by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of COVID-19 IgM/IgG Antibody Rapid Test Kits by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    RDT(Rapid Diagnostic Test)
    ELISA(Enzyme-linked Immunosorbent Aassay)
    Neutralization Assay

    Segment by Application
    Hospital
    Special Clinic
    Research Institutions

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Cellex
    RayBiotech
    Biopanda
    BioMedomics
    GenBody
    SD Biosensor
    Advaite
    Premier Biotech
    Epitope Diagnostics
    CTK Biotech
    Creative Diagnostics
    Eagle Biosciences
    Sure Biotech
    Sugentech
    Sensing self
    Euroimmun AG
    PharmACT
    Liming Bio
    Beijing Wantai
    Livzon Diagnostics
    Shenzhen BioEasy Biotechnology
    Orient Gene Biotech
    INNOVITA
    Dynamiker
    Guangzhou Wonfo Bio-Tech

    Buy now